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Abstract
Background: Carbapenemes are a good choice for treatment of infections caused by multidrug resistant Pseudomonads aeruginosa.
The emergence of carbapenem resistance has become a major problem in treatment of this organism especially among immuno-
compromised patients including burn patients.
Objectives: The aim of this study was to investigate carbapenem-resistance mechanisms among burn patients in Tehran, Iran, dur-
ing 2014 - 2015.
Methods: The antibiotic resistance phenotypic test was accomplished by the Kirby Bauer disk diffusion method. The phenotypic
investigation of metallo-beta-lactamase (MBL) producers was evaluated by the combined disk diffusion test (CDDT) method. The
prevalence of MBL genes, including blaIMP-1 and blaVIM-1 was evaluated by polymerase chain reaction (PCR) and sequencing methods.
Amplification of oprD was performed by PCR and the results of sequencing were aligned with wild-type P. aeruginosa strain PAO1.
Results: A total of 100 P. aeruginosa were investigated, of which, 95 were resistance to imipenem. Out Of 95 imipenem resistant
isolates„ 81 (85.2%) were MBL producers. Among all isolates, 13 strains carried the blaIMP-1 gene, whereas all of the strains were negative
for the blaVIM-1 gene. Amplification of OprD porin was performed for all 100 P. aeruginosa strains. Two insertion sequences (ISs)
including ISPpu21 and ISPa1328 were detected in PCR products of OprD gene, that were larger than expected.
Conclusions: The prevalence ofβ-lactamase-producing isolates and their isolation from life-threatening infections in burn patients
is increasing at an alarming rate worldwide. Also, we have identified two novel IS elements, ISPa1328 and ISPpu21, in P. aeruginosa iso-
lates from hospitals in Tehran, Iran. In most of the isolates, insertional inactivation of oprD by ISPa1328 and ISPpu21 were associated
with carbapenem resistance.
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1. Background
Burn patients are at risk of acquiring infection be-
cause of their damaged skin and impaired immune sys-
tem. Pseudomonas aeruginosa is a prevalent cause of noso-
comial infections around the world and, as an opportunis-
tic pathogen, causes other infections such as septicemia,
pneumonia, endocarditis, urinary tract infection, skin, ear
and eye infections, as well as being a leading cause of mor-
bidity and mortality among hospitalized burn patients (1,
2). Due to the intrinsic and acquired resistance mecha-
nisms to various antimicrobial agents, there is a serious
challenge for choosing the appropriate antibiotic for treat-
ing infections by P. aeruginosa (1). Currently, carbapen-
ems are used for the treatment of antibiotic resistant P.
aeruginosa infections by targeting cell wall through bind-
ing and inactivating penicillin-binding proteins (PBPs) (3,
4). Unfortunately, the emergence of carbapenem resis-
tance among P. aeruginosa isolates has challenged the suc-
cess of these antibiotics for therapeutic purposes (3). Car-
bapenem resistance in P. aeruginosa is associated with mu-
tation in the oprD gene encoding the outer membrane
porin (OprD) that leads to repression or inactivation of the
oprD. The other mechanism of carbapenem resistance is in-
sertional inactivation of oprD by insertion sequence (IS) el-
ements, which subsequently increases the activity of mul-
tidrug eﬄux pumps such as MexAB-OprM. The two men-
tioned mechanisms are due to mutations in chromosomal
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genes. Another known mechanism that may cause resis-
tance are transferable elements which code for carbapen-
emases, especially IMP and VIM that belong to metallo-β
lactamases and are responsible for the emergence of resis-
tance to all β-lactams except for aztreonam (2, 5-7).
2. Objectives
The aim of this study was to investigate the mecha-
nisms of carbapenem resistance in P. aeruginosa isolated
from burn patients hospitalized in Shahid Motahari Hos-
pital, Tehran, Iran, during 2014 - 2015.
3. Methods
3.1. Bacterial Identification
From march 2014 to march 2015, 100 nonduplicate
nonconsecutive P.aeruginosa strains were isolated from
burn patients hospitalized in Shahid Motahari Hospital
(Tehran, Iran). Prior to sampling, the wounds were washed
with isotonic saline. Samples were placed in Stuart’s me-
dia, cultured on the blood agar and Mac-onkey agar (Merck
Co) and incubated at 37°C for 24 hours. All isolates were
identified by conventional biochemical methods (8) in-
cluding the catalase test, oxidase test, reaction on Tripple
Sugar Iron (TSI) medium, oxidation/fermentation of glu-
cose using the oxidative-fermentative (OF) medium and
growth ability at 42°C.
3.2. Antimicrobial Susceptibility Testing
An antimicrobial susceptibility test was performed
by the Kirby Bauer disk diffusion method on the Muller
Hinton agar based on clinical and laboratory standards
institute (CLSI, 2013) guidelines. The antibiotic disks
(Mast, UK) used during this study were imipenem (IPM:
10 µg), meropenem (MEM: 10 µg), doripenem (DOR: 10
µg), ceftazidime (CAZ: 30 µg), cefotaxime (CTX: 30µg),
amikacin (AK: 30µg), ticarcillin (TIC: 75µg) , piperacillin
(PRL: 100 µg), piperacillin/tazobactam (PTZ: 100/10 µg),
ciprofloxacin (CIP: 5µg), cefepime (FEP: 30µg), aztreonam
(ATM: 30 µg), gentamicin(GEN: 10 µg) and colistin (Co: 10
µg). Pseudomonas aeruginosa ATCC 27853 was used as the
control strain.
3.3. Minimum Inhibitory Concentration
Strains resistant to imipenem, meropenem, cef-
tazidime and ciprofloxacin by the disk diffusion test were
rechecked by the broth microdilution method according
to the guidelines of the CLSI 2013 (CLSI). P. aeruginosa ATCC
27853 was used as the control strain.
3.4. Phenotypic Detection of Metallo-Beta-Lactamase
A combined disk diffusion test (CDDT) was per-
formed for the identification of MBLs by imipenem and
meropenem (Mast Group, Merseyside, UK) alone and in
combination with EDTA. An inhibition zone diameter
difference between the discs and discs + EDTA of ≥ 7 mm
was interpreted as positive for the presence of an MBL (9).
P. aeruginosa PA53 (ACCESSION: KM359726) was used as the
control strain.
3.5. DNA Extraction
DNA was extracted using the DNA extraction kit (GeNet
Bio Company, Korea, Cat. No. K-3000) according to the
manufacturer’s guidelines.
3.6. Detection of blaIMP-1 and blaVIM-1 Genes by Polymerase
Chain Reaction
The blaIMP-1, blaVIM-1 and oprD genes were amplified by
PCR, using the primers described in Table 1. Three µL of
the extracted DNA (100 ng/µL) was added to a final vol-
ume of 25 µL PCR mixture containing 12.5 µL of 2×Master
Mix (Sinaclon- Iran, CAT. NO.:PR901638), including 1× PCR
buffer, 3mmol/L MgCl2, 0.4mmol/L dNTP, and 0.08 IU Taq
DNA polymerase,1 µL of 10 pmol/L from each primer and
7.5 µL of sterile distilled water.
The amplification program was set at 36 cycles of de-
naturation at 94°C for 45 seconds, annealing at 47°C to
54°C, according to the primers (Table 1), for 45 seconds
and elongation at 72°C for 45 seconds. The amplified prod-
ucts were visualized after electrophoresis in 1% agarose
gels at 95 V for 45 minutes in 1X TBE containing ethidium
bromide under UV irradiation. P. aeruginosa PA53 (ACCES-
SION: KM359726) for IMP-1, P.aeruginosa Psa1 (ACCESSION:
KT313641) for VIM-1 gene and P.aeruginosa PAO1 for oprD
gene were used as the control strains.
3.7. Sequencing
The PCR purification kit (Bioneer Co., Korea) was used
to purify PCR products. Purified PCR products were used
as templates and sent for sequencing analysis at Bioneer
Company, Korea. Sequencing of both strands of the oprD
PCR products necessitated two additional internal primers
including oprDF2 and oprDR2 (Table 1). The nucleotide se-
quences were analyzed with the Chromas 1.45 software and
BLAST in NCBI.
3.8. Statistical Analysis
The statistical analysis was performed with MINITAB16.
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Table 1. Primers Used for Polymerase Chain Reaction and Sequencing
Target Gene Sequence of Primers (5 to 3 ) Product Size (bp) Annealing Temperature
VIM1-F GATGGTGTTTGGTCGCATA
390 54°C
VIM1-R CGAATGCGCAGCACCAG
IMP1-F GAAGGCGTTTATGTTCATAC
587 47°C
IMP1-R GTAAGTTTCAAGAGTGATGC
OprDF1 ATGAAAGTGATGAAGTGGAG
1329 50°C
OprDR1 CAGGATCGACAGCGGATAGT
OprDF2 AACCTCAGCGCCTCCCT
Primers for Sequencing
OprDR2 AGGGAGGCGCTGAGGAT
4. Results
A total of 100 P. aeruginosa strains were isolated from
burn patients. Twenty-six strains (26%) were isolated from
females and 74 (74%) from males.The average age of pa-
tients was from 2 to 72 years. (distribution shown in Figure
1).
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Figure 1. The Distributions of Age in Burn Patients
The resistance rate of the 100 P. aeruginosa isolates
according to the Kirby-Bauer method was as follows: 95
(95%) to imipenem, 95 (95%) to meropenem, 94 (94%) to
doripenem, 75 (75%) to ceftazidime, 93 (93%) to cefepime,
94 (94%) to ciprofloxacin, 91 (91%) to amikacin, 90 (90%) to
aztreonam, 98 (98%) to ticarcillin, 90 (90%) to piperacillin,
82 (82%) to piperacillin/tazobactam, 95 (95%) to gentamicin
and 0 (0%) to colistin.
The results of the MIC test for imipenem, meropenem,
ceftazidime and ciprofloxacin on P. aeruginosa isolates are
shown in Table 2.
Using the combination disk diffusion test method,
it was found that among 95 imipenem nonsusceptible
P.aeruginosa strains 81 (%85.2) were MBL producers (Figure
2).
The prevalence of the blaIMP-1 gene among MBL-
producing P. aeruginosa isolates was 13 of 81 (16.04%),
Figure 2. Combined Disk Test Using Imipenem and Imipenem + EDTA. Imipenem
+ EDTA Disk (on the Left) Produced ≥ 7 mm Larger Zone of Inhibition Than the
Imipenem Disk (on the Right)
while the blaVIM-1 gene was not detected (Figure 3). The
nucleotide sequences data reported in this paper have
been submitted to the GenBank sequence database and
assigned the accession number KT313640 for the blaIMP-1
gene.
Amplification of the oprD porin was performed for all
100 P. aeruginosa isolates. Surprisingly, 22 isolates had
larger PCR products than expected. The oprD gene was not
detected in 9 isolates. Sequencing results and alignment of
PCR products of oprD compared with Pseudomonas aerugi-
nosa PAO1 revealed that these large inserts corresponded to
ISPpu21 (accession number: KT728193) and ISPa1328 (acces-
sion number:KT736319) (Figures 4 and 5).
The nucleotide sequence data reported in this study
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Table 2. The Result of MIC Test for Imipenem, Meropenem, Ceftazidime and Ciprofloxacin on P. aeruginosa Isolates
Antibiotics MIC(µg/mL)
Resistance Intermediate Sensitive
Imipenem 90 (90%) 5 (5%) 5 (5%)
Meropenem 90 (90%) 5 (5%) 5 (5%)
Ceftazidime 72 (72%) 3 (3%) 25 (25%)
Ciprofloxacin 96 (96%) 1 (1%) 3 (3%)
Figure 3. PCR Products of blaIMP-1 Producing Strains of P. aeruginosa Isolates
N: control negative, P: control positive, 1,2 positive isolates
were submitted to the GenBank sequence database and
assigned under the accession number KT313640 for the
blaIMP-1 gene.
5. Discussion
Pseudomonas aeruginosa is one of the most prevalent
causes of nosocomial infections and its resistance to to an-
tibiotics is increasing among strains isolated from burn
patients (10, 11). According to the epidemiological research,
which has been accomplished around the world, the
prevalence of drug resistance especially MBL-coding genes
among P. aeruginosa strains has been increased among dif-
ferent countries, regions and even hospitals which are lo-
cated in various geographical regions. Due to the clini-
cal significance of MBL- producing organisms, isolation of
such strains from a patient should be carefully managed
(12). The results of this study showed that among all antibi-
otics, the highest resistance rate was for the following an-
tibiotics: 98% to ticarcillin, 95% to imipenem, meropenem,
gentamicin and 94% to doripenem and ciprofloxacin. All
the isolates were susceptible to colistin. So, in our study
colistin was the most effective antibiotic for treatment of P.
aeruginosa infections. Two previous studies conducted by
Fallah et al. (10) and Shahcheraghi et al. (13) are similar to
our study, which showed resistance against various antibi-
otics such as beta-lactams (including the 3rd generation of
cephalosporins and carbapenemas), aminoglycosides and
fluoroquinolons. Saffari et al. reported the imipenem re-
sistance rate of 58.7% among P. aeruginosa isolates in Ah-
waz, which was lower than what we have found in our
study (14). However, Radan et al. study, in Isfahan, was in
agreement with our results: 96% of P. aeruginosa strains
which were isolated from hospitalized patients at the burn
unit showed resistance to imipenem. Another report, in
contrast with our study, found a resistance rate of 21% to
imipenem among P. aeruginosa isolates from burn patients
in Kurdistan (15). Different studies showed increased re-
sistance of P. aeruginosa to different antibiotics that are
caused by indiscriminate and inappropriate use of antibi-
otics. This antibiotic resistance can be controlled by appro-
priate antibiotic prescriptions, including low-resistance-
potential antibiotics (14). Production of MBLs is one of the
carbapenem resistance mechanisms among P. aeruginosa
strains (15). In the current study, 85.2% of the isolates were
positive for MBL production, which was higher than other
studies conducted by Fallah et al. with 58.2% and Hakemi
et al. with 17.3% MBL producer isolates (9, 16). In Kurdis-
tan and Ahwaz, 22% and 19.5% of P. aeruginosa strains iso-
lated from burn patients were identified as MBL-producing
isolates (14). Another study performed by Sadrei et al. in-
dicated a higher incidence of MBLs than our study (17).
All phenotypic results were rechecked by molecular meth-
ods. According to the PCR results among MBL producing
isolates, 13 (16.04%) isolates were positive for the blaIMP-1
gene; however, the presence of this gene has been previ-
ously proved to be variable in different regions and the
blaVIM-1 gene has not been detected in P. aeruginosa. The re-
sult of blaVIM-1 in this study is similar to those of two other
studies from Iran that were individually performed by Fal-
lah et al. (9) and Hakemi et al. in 2012 (16) and the inci-
dence of blaIMP-1 in the mentioned studies was lower than
ours and also are in contrast to those of two other stud-
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Figure 4. Sequence of the ISPpu21 Located in the oprD Gene
ies from Iran: in Tehran 11.43% of the isolated P.aeruginosa
strains and in Ahwaz 19.51% of P.aeruginosa isolates were re-
ported to have the blaVIM gene (16). Also, Saderi et al. re-
ported that 94% of P.aeruginosa isolates from Tehran were
identified as MBL producers and carried the blaVIM-2 gene
(17). In another study Ghamgosha et al. detected blaVIM-1
gene, while none of them were positive for the blaIMP-1 gene
(18). Also, Radan et al. reported that all of the imipenem-
resistant P. aeruginosa isolates were MBL-positive, and 107
out of 144 (74.3%) of the MBL isolates were positive for the
blaIMP gene (15). So, these data are in contrast to ours and
this may be related to differences in the time of the studies
and consequently to changes in antibiotics prescriptions
and antibiotic resistance patterns. These results indicated,
participation of other factors such as other MBL- encod-
ing genes, lack of oprD (which results in membrane per-
meability change), the over expression of eﬄux pumps or
chromosomal AmpC beta-lactamase. In the current study,
amplification of oprD showed the presence of the larger
fragments of the oprD gene in some isolates, which were
associated with ISPpu21 and ISPa1328 insertion sequences.
In Al-Bayssari et al. (19) study, ISPa1328 and in Estepa et
al. study ISPpu21 insertion sequence was detected in the
oprD gene, which was in accordance with our study (20,
19). Earlier studies conducted by Diene et al. in 2013 have
demonstrated the oprD gene disrupted by ISpa46 inser-
tion sequences (21). Other IS elements disrupting the oprD
gene have been detected in different regions such as Spain
(ISPa133) and the United States (ISPa8) (12, 22). These re-
sults demonstrate that insertional inactivation of oprD can
cause carbapenem resistance among P.aeruginosa strains
(22). In spite of many unclear reasons about various stud-
ies, this discrepancy may be related to differences in time
of the studies, geographical regions, kind of infections, an-
tibiotic therapy regimens or the kinds of primers, which
have been used in the study.
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Figure 5. Sequence of the ISPa1328 Located in the oprD Gene
5.1. Conclusion
The prevalence of β-lactamase-producing isolates and
their isolation from life-threatening infections is increas-
ing at an alarming rate worldwide. Intense pressure for the
use of antimicrobial drugs in patients, results in eradica-
tion of normal flora and may be a situation of MDR isolates
substitution. It was shown in this study that β-lactamase
producing P.aeruginosa strains are an emerging threat and
should be supervised by implementation of timely identi-
fication and strict isolation methods that will help to re-
duce their severe outcomes and mortality rate in these
patients. Also, we have identified two novel IS elements,
ISPa1328 and ISPpu21, in P. aeruginosa isolates from hospi-
tals in Tehran, Iran. In most of the isolates, insertional in-
activation of oprD by ISPa1328 and ISPpu21 was associated
with carbapenem resistance.
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